InsidersTradesSigma
Track the Straumann Holding AG stock price and the full directors' dealings record of the company, a listed issuer based in Switzerland. Shares trade on the CH market, under the authority of SIX SER. Operating in the Healthcare & Pharma sector, Straumann Holding AG has logged 96 reports. Market capitalisation: €15.8bn. The latest transaction was reported on 30 June 2026 (Sale). Every trade is accessible without an account.
96
Insider Decl.
n/a
Thresholds
€5m
32 ops.
Buy Volume
€145m
64 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Straumann Holding AG Buy (bullish), based on 18 analysts. Average price target: CHF 110.33.
32Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,396 of 28,753 companies
58.4
score / 100
Value37
Quality80
FCF yld1.8%
Earn yld2.3%
EV/EBITDA25.0x
ROE17%
Gross mgn69%
Net mgn14%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 June 2026
Declarations96 total
●
Anonymous (an executive member of the board of directors / member of senior management)
1,100 shares@ CHF 106.400.0007% mcap11.7% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q6U00036
●
Anonymous (Executive member of the board of directors / member of senior management)
1,100 shares@ CHF 106.400.0007% mcap1.5% of flowISIN CH1175448666SIX:T1Q6U00036
●
Anonymous (an executive member of the board of directors / member of senior management)
1,050 shares@ CHF 94.140.0007% mcap11.3% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q6100010
●
Anonymous (an executive member of the board of directors / member of senior management)
1,742 shares@ CHF 64.560.0008% mcap14.5% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q57000C5
●
Anonymous (an executive member of the board of directors / member of senior management)
2,517 shares@ CHF 64.560.0012% mcap20.9% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q57000B7
●
Anonymous (an executive member of the board of directors / member of senior management)
4,646 shares@ CHF 64.560.0022% mcap38.6% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q57000G6
●
Anonymous (an executive member of the board of directors / member of senior management)
1,607 shares@ CHF 64.560.0008% mcap13.4% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q57000D3
●
Anonymous (an executive member of the board of directors / member of senior management)
1,510 shares@ CHF 64.560.0007% mcap12.6% of flowSIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q57000F8
●
Anonymous (Executive member of the board of directors / member of senior management)
2,517 shares@ CHF 64.560.0012% mcap2.2% of flowISIN CH1175448666SIX:T1Q57000B7
●
Anonymous (Executive member of the board of directors / member of senior management)
1,607 shares@ CHF 64.560.0008% mcap1.4% of flowISIN CH1175448666SIX:T1Q57000D3
●
Anonymous (Executive member of the board of directors / member of senior management)
1,510 shares@ CHF 64.560.0007% mcap1.3% of flowISIN CH1175448666SIX:T1Q57000F8
●
Anonymous (Executive member of the board of directors / member of senior management)
4,646 shares@ CHF 64.560.0022% mcap4.0% of flowISIN CH1175448666SIX:T1Q57000G6
●
Anonymous (Executive member of the board of directors / member of senior management)
1,742 shares@ CHF 64.560.0008% mcap1.5% of flowISIN CH1175448666SIX:T1Q57000C5
1,800 shares@ CHF 81.98160.0011% mcap0.1% of flowISIN CH1175448666SIX:T1Q3V000E1
634,400 shares@ CHF 80.560.37% mcap39.6% of flowISIN CH1175448666SIX:T1Q3P00082
1,400 shares@ CHF 76.37990.0008% mcap0.1% of flowISIN CH1175448666SIX:T1Q3K00034
3,800 shares@ CHF 77.700.0022% mcap0.2% of flowISIN CH1175448666SIX:T1Q3J00036
31,250 shares@ CHF 80.37350.019% mcap2.0% of flowISIN CH1175448666SIX:T1Q3G000G5
●
Anonymous (Executive member of the board of directors / member of senior management)
430 shares@ CHF 92.78060.5% of flowISIN CH1175448666SIX:T1PC800040
34,625 shares@ CHF 100.03052.6% of flowISIN CH1175448666SIX:T1PBP000A6
564 shares@ CHF 104.200.0% of flowISIN CH1175448666SIX:T1PBD00077
2,336 shares@ CHF 94.82450.2% of flowISIN CH1175448666SIX:T1P9500010
1,275 shares@ CHF 94.0050.1% of flowISIN CH1175448666SIX:T1P8F00059
●
Anonymous (Executive member of the board of directors / member of senior management)
290 shares@ CHF 104.400.4% of flowISIN CH1175448666SIX:T1P7G00026
40,281 shares@ CHF 104.50333.2% of flowISIN CH1175448666SIX:T1P6O00030
25 of 96 declarations
About Straumann Holding AG
Straumann Holding AG is a leading global player in dental implantology and orthodontic solutions. Listed on the SIX Swiss Exchange (SMI/SPI) in Switzerland, the company offers investors a defensive healthcare profile with growth supported by innovation, demographic aging, and rising oral-care demand. Headquartered in Basel, Switzerland, Straumann was founded in 1954 and has evolved into an international reference in tooth replacement and aesthetic dentistry. ([straumann.com](https://www.straumann.com/us/en/dental-professionals/about/the-straumann-group.html?utm_source=openai)) The group operates across several complementary business lines: implantology, prosthetics, biomaterials, digital solutions, and orthodontics. Its portfolio includes the Straumann, Neodent, Medentika, Anthogyr, and ClearCorrect brands, along with technology partnerships and digital workflow tools. This broad offering allows the company to cover a significant part of the treatment chain, from implants to CAD/CAM restorations, guided surgery, intra-oral scanning, and clear aligners. ([straumann.com](https://www.straumann.com/group/en/home/about/contact-us/contact-our-brands.html?utm_source=openai)) From a competitive standpoint, Straumann stands out through strong scientific credibility, a broad global distribution network, and close relationships with dental professionals, laboratories, and dental service organizations. The group says its products, solutions, and services are available in more than 100 countries, giving it a highly diversified geographic footprint. Its strategy is built around clinical education, product innovation, manufacturing quality, and the gradual integration of digital technologies into treatment workflows. ([straumann.com](https://www.straumann.com/us/en/dental-professionals/about/the-straumann-group.html?utm_source=openai)) Recent developments point to continued operational momentum. The 2024 and 2025 disclosures highlight solid commercial trends, market-share gains, strategic execution improvements, and further progress in digital offerings. Straumann also continued to streamline its portfolio, including the divestment of DrSmile, in order to focus resources on its core businesses with the strongest conviction. Full-year 2025 results, published in early 2026, indicated continued organic growth and strategic progress despite a more volatile macroeconomic and geopolitical backdrop. ([straumann.com](https://www.straumann.com/group/en/discover/annualreport/2024.html?utm_source=openai)) For francophone investors, Straumann combines exposure to a structurally attractive dental healthcare market with strong brand leadership and innovation potential, while remaining sensitive to foreign exchange movements, discretionary demand in certain segments, and commercial execution in key geographies.
